Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation

• Main Authors: Cortes, J., Lipton, J.H., Rea, D., Digumarti, R., Chuah, C., Nanda, N., Benichou, A.-C., Craig, A.R., Michallet, M., Nicolini, F.E., Kantarjian, H.
• Other Authors: DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
• Format: Article
• Published: 2016
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/128647
• Institution: National University of Singapore

10.1182/blood-2012-03-415307